Home › Funds › Advisors Asset Management, Inc. › GILD
Advisors Asset Management, Inc. position in GILD
GILEAD SCIENCES INC · Health Care
Advisors Asset Management, Inc. reported holding 162,623 shares of GILD (GILEAD SCIENCES INC) in its Q4 2025 13F filing — a position valued at US$20.0M, representing 0.34% of its reported portfolio and ranking #46 among its reported holdings. Advisors Asset Management, Inc. has disclosed GILD holdings in 10 of the last 10 reported quarters, going back to Q3 2023.
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
How Advisors Asset Management, Inc.'s GILD position evolved
Advisors Asset Management, Inc. first disclosed a stake in GILD in Q3 2023 at 316,739 shares (US$23.7M). The position peaked in Q1 2025 at 239,934 shares, worth US$26.9M. Across 10 filings, Advisors Asset Management, Inc. increased the stake 2 time(s), trimmed it 7 time(s) and left it unchanged 0 time(s). The most recent filing (Q4 2025) shows 162,623 shares valued at US$20.0M — a reduction of -7,634 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 316.74K | $23.74M | New |
| Q4 2023 | 274.22K | $22.21M | Reduce |
| Q1 2024 | 262.50K | $19.23M | Reduce |
| Q2 2024 | 273.73K | $18.78M | Add |
| Q3 2024 | 254.84K | $21.37M | Reduce |
| Q4 2024 | 225.58K | $20.84M | Reduce |
| Q1 2025 | 239.93K | $26.88M | Add |
| Q2 2025 | 206.03K | $22.84M | Reduce |
| Q3 2025 | 170.26K | $18.90M | Reduce |
| Q4 2025 | 162.62K | $19.96M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GILD and 13F data
GILD (GILEAD SCIENCES INC) is a Health Care company. 35 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.45B), Capital World Investors (US$5.18B), Capital World Investors (US$5.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GILD
- Fidelity Management & Research (FMR) 66.87M sh · $8.45B · Q2 2026
- Capital World Investors 40.99M sh · $5.18B · Q2 2026
- Capital World Investors 40.99M sh · $5.18B · Q2 2026
- Invesco Ltd 39.82M sh · $5.03B · Q2 2026
- PRICE T ROWE ASSOCIATES INC /MD/ 30.00M sh · $3.79B · Q2 2026
- Dodge & Cox 23.68M sh · $2.99B · Q2 2026
- DODGE & COX 23.68M sh · $2.99B · Q2 2026
More on Advisors Asset Management, Inc.
FAQ
How long has Advisors Asset Management, Inc. held GILD?
Advisors Asset Management, Inc. has disclosed GILD holdings in 10 of the last 10 reported quarters, going back to Q3 2023.
What is Advisors Asset Management, Inc.'s current position in GILD?
As of Q4 2025, Advisors Asset Management, Inc. holds 162.62K shares of GILD (GILEAD SCIENCES INC), valued at $19.96M, representing 0.34% of its reported portfolio and ranking #46.
Has Advisors Asset Management, Inc. been buying or selling GILD?
In the latest 13F filing (Q4 2025), Advisors Asset Management, Inc. reduced its position in GILD. The position peaked in Q1 2025 at 239.93K shares.
Which other funds hold GILD?
Other major institutional holders of GILD include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.